why choose us

300×250 Ad Slot

Research Article: N-Methyladenosine-Modified LEAWBIH Drives Hepatocellular Carcinoma Progression through Epigenetically Activating Wnt/?-Catenin Signaling

Date Published: 2023-11-06

Introduction:
Liver cancer is the sixth most common malignancy and the third leading cause of cancer-related deaths worldwide. Hepatocellular carcinoma (HCC) is the most common type of liver cancer. Surgical resection and liver transplantation are the preferred therapies for early-stage HCCs. For recurrent and advanced-stage HCCs, systemic therapies, including tyrosine kinase inhibitors, immune checkpoint inhibitors, and monoclonal antibodies, are currently utilized. However, the prognosis of these advanced-stage HCCs is still…

Read more

300×250 Ad Slot